SCHEMBL1610185

SCHEMBL1610185

COC(=O)c1nc(C2CC2)nc(N(C)c2ccccc2N2CCOCC2)c1Cl

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.41
KDM4E B2RXH2 2/20 0.41
MAPK1 P28482 2/20 0.41
SMN1; SMN2 Q16637 3/20 0.39
NPSR1 Q6W5P4 3/20 0.39
LMNA P02545 2/20 0.36
PKM P14618 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C19 P33261 1/20 0.36
MAPT P10636 3/20 0.35
TSHR P16473 3/20 0.35
NPC1 O15118 2/20 0.35
GAA P10253 1/20 0.35
ATM Q13315 1/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
RAB9A P51151 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35
NAPEPLD Q6IQ20 1/20 0.35
POLB P06746 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1610302 0.83 NTSR1 (0.38) MAPK1SMN1; SMN2TSHRNPC1RAB9A
SCHEMBL1608874 0.82 SLC6A3 (0.39) ALDH1A1KDM4EMAPK1SMN1; SMN2LMNA
SCHEMBL1609761 0.81 RXRA (0.36) ALDH1A1KDM4EMAPK1SMN1; SMN2LMNA
SCHEMBL1609071 0.81 SLC6A3 (0.33) ALDH1A1KDM4EMAPK1SMN1; SMN2LMNA
SCHEMBL1609778 0.78 RBP4 (0.37) CYP1A2CYP2C19MAPTTSHRMEN1
SCHEMBL1609555 0.78 ALDH1A1 (0.36) ALDH1A1KDM4EMAPK1SMN1; SMN2NPSR1
SCHEMBL1610187 0.78 GAA (0.44) ALDH1A1KDM4EMAPK1SMN1; SMN2NPSR1
SCHEMBL1609691 0.77 SLC6A3 (0.42) ALDH1A1KDM4EMAPK1SMN1; SMN2LMNA
SCHEMBL1610229 0.77 SLC6A3 (0.34) ALDH1A1KDM4EMAPK1SMN1; SMN2LMNA
SCHEMBL1609469 0.76 PDE4D (0.36) ALDH1A1KDM4ESMN1; SMN2NPSR1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110086759-A1 CHEMICAL COMPOUNDS SYNGENTA CROP PROTECTION, INC. (US) 2011-04-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110086759-A1 CHEMICAL COMPOUNDS DDT, PNPO, CBR3 ALDH1A1 1562/4885KDM4E 2613/4885MAPK1 1418/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.